Nebulized corticosteroids in the management of acute exacerbation of COPD

Gaude, G. S.; Nadagouda, S.
October 2010
Lung India;Oct-Dec2010, Vol. 27 Issue 4, p230
Academic Journal
Acute exacerbations in chronic onstructive pulmonary disease (COPD) are common and systemic steroids play an important role in the management of these cases along with the bronchodilators. Nebulized budesonide is being used in the acute attacks of bronchial asthma either in children or in adults. But the role of nebulized steroids in acute exacerbation of COPD is not much studied in the literature. In this clinical review we have evaluated the role of nebulized corticosteroids in the management of acute exacerbation of COPD (AECOPD). Through Medline, Pubmed and Embase we analyzed the various studies that has been done to study the role of nebulized corticosteroids in the management of acute exacerbation of COPD. The key words used for the search criteria were: acute exacerbation, COPD, nebulized corticosteroids, budesonide, fluticasone. Only eight studies were found which had evaluated the role of nebulized corticosteroids in acute exacerbations of COPD. All these studies had used nebulized budesonide in AECOPD in different dosages, and had been compared with both either parental or oral steroids, and standard bronchodilator therapy. All the studies had found the clinical efficacy of nebulized budesonide to be of similar extent to that of either parental or oral steroids in AECOPD. Side effects profile of nebulized budesonide was minimal and acceptable as compared to systemic steroids. Nebulized budesonide may be an alternative to parental/oral prednisolone in the treatment of acute exacerbations of COPD but further studies should be done to evaluate its long-term impact on clinical outcomes after an initial episode of COPD exacerbation.


Related Articles

  • The WISDOM of inhaled corticosteroids in COPD. Halpin, David M. G.; Quint, Jennifer K. // Thorax;Dec2014, Vol. 69 Issue 12, p1071 

    The article focuses on a study showing the effective role of inhaled corticosteroids (ICS) along with bronchodilators in patients with Chronic obstructive pulmonary disease (COPD) reducing the risk of exacerbations. Topics discussed include WISDOM study conducted to investigate the role of ICS,...

  • New Addition. Werner, Alison // RT: The Journal for Respiratory Care Practitioners;Jan2013, Vol. 26 Issue 1, p20 

    The article offers a preview of the drug tiotropium as an add-on aerosol therapy, which is currently under investigation by Ridgefield, Conn-based Boehringer Ingelheim Pharmaceuticals Inc, a U.S. based pharmaceutical company.

  • Phenotyping provides potential for a personalized approach in patients with chronic obstructive pulmonary disease (COPD).  // Drugs & Therapy Perspectives;Mar2015, Vol. 31 Issue 3, p89 

    Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disorder, with clinical response to the various available treatment options differing according to disease characteristics. At least three different COPD phenotypes, each providing unique prognostic and therapeutic...

  • Oral corticosteroids for asthma or COPD were dispensed to 2.6% of Norwegians aged 7 years or over in 2004-5. Selstad, Gro Marie; Melbye, Hasse // Primary Care Respiratory Journal;Sep2011, Vol. 20 Issue 3, p332 

    The article focuses on the use of oral corticosteroids for asthma or chronic obstructive pulmonary disease (COPD). It states the frequency of oral corticosteroid prescription in a defined population can over time indicate the prevalence of moderate to severe exacerbations of asthma or COPD and...

  • Frequency of non-asthma GP visits predicts asthma exacerbations: an observational study in general practice. Hyland, Michael E.; Whalley, Ben; Halpin, David M. G.; Greaves, Colin J.; Seamark, Clare; Blake, Sue; Pinnuck, Margaret; Ward, David; Hawkins, Adam L; Seamark, Dave // Primary Care Respiratory Journal;Dec2012, Vol. 21 Issue 4, p405 

    Background: Being able to identify patients at risk of exacerbations is useful as it enables resources to be targeted at these patients. Aims: To test the theoretically-derived prediction that the frequency of non-asthma related visits to the general practitioner (GP) predicts exacerbations....

  • Masterclass: using combination inhalers in COPD. Bostock-Cox, Beverley // Practice Nurse;7/18/2014, Vol. 44 Issue 7, p13 

    The article aims to focus on the use of combination inhalers in managing chronic obstructive pulmonary disease (COPD) and the drugs, devices and potential side effects of treatments available. Topics discussed include treatment options entering the market, emphasis of National Institute for...

  • NICE guidance for COPD.  // Nursing & Residential Care;Feb2014, Vol. 16 Issue 2, p69 

    No abstract available.

  • Would this long-acting bronchodilator be better for your patient? Gwynne, Mark; Mounsey, Anne // Clinician Reviews;Jun2012, Vol. 22 Issue 6, p36 

    The article presents a case study of a 60-year-old patient diagnosed with chronic obstructive pulmonary disease (COPD). The patient was given long-acting bronchodilators tiotropium to prevent exacerbations. The study revealed a 14% reduction in risk for a moderate exacerbation which is...

  • Tiotropium for COPD -- The New Standard? Elliott, William T. // Primary Care Reports;May2011 Pharmacology Watch, p1 

    The article presents the results of a study on the anticholinergic drug tiotropium which shows that it is more effective in preventing exacerbation in patients with chronic obstructive pulmonary disease (COPD).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics